The Natural Course of Impaired Fasting Glucose.

The Natural Course of Impaired Fasting Glucose. Adv Exp Med Biol. 2020 Aug 08;: Authors: Święcicka-Klama A, Połtyn-Zaradna K, Szuba A, Zatońska K Abstract Impaired glucose regulation, including diabetes and prediabetes, poses a huge global problem not only in health but also in the epidemiological and economic areas. These disorders are often detected too late or remain unrecognized. The article aims to provide a review of the prevalence, etiology, and natural history of impaired fasting glucose (IFG). We focus on the progression of isolated IFG to full-fledged type 2 diabetes and the factors conducive to the development of diabetes. The knowledge about it could help design an optimal management program for the prevention of diabetes in patients with IFG; a program that would be patient-tailored and based on the underlying pathophysiology. PMID: 32767267 [PubMed - as supplied by publisher]
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research

Related Links:

Publication date: December 2020Source: Journal of Functional Foods, Volume 75Author(s): Cai-Jing He, Li-Qun Ma, Muhammad Sarfaraz Iqbal, Xian-Ju Huang, Jun Li, Guang-Zhong Yang, Awais Ihsan
Source: Journal of Functional Foods - Category: Nutrition Source Type: research
Conclusion: This real-world evidence complements the results observed in randomized controlled trials, for meaningful effectiveness with the use of empagliflozin-linagliptin fixed dose combination in the Indian outpatient setting. More evidence may facilitate further characterization of clinical value of this promising combination. PMID: 32978926 [PubMed - in process]
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
Publication date: Available online 28 September 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Evangelia Makri, Marina Kita, Antonis Goulas, Paraskevi Papaioannidou, Zoe A. Efstathiadou, Fotini Adamidou, Stergios A. Polyzos
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Publication date: Available online 28 September 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Li Jinfeng, Li Ya, Ma Weiguo, Liu Yishan, Yin Xiaohong, Xie Chuanqing, Bai Jiao, Zhang Min
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Publication date: Available online 28 September 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Rajiv Kovil, Tejas Shah, Manoj Chawla, Shefali Karkhanis, Dakshata Padhye, Ami Sanghvi, Mayura Choudhari Kale, Purvi Chawla, Nikhil Prabhu, Vinay Dhandhania, Kiran Shah, Manish Sachdev, Vinod Methil, Snehal Tanna, Kamlesh Nayak, Seema Bagri, Pratiksha Patil, Alka Gandhi, Sheetal Aversekar, Ragini Maheshwari
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Publication date: Available online 28 September 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Ali SN, Khunti K
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
TYPE 2 diabetes can cause long term damage to a number of body parts. The eyes are incredibly susceptible to damage caused by living with the condition and experiencing any of these six symptoms could mean you may be at risk.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
The new data further supports the health benefits of being active in patients with type 2 diabetes, says and expert.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news
ConclusionsCollectively, these data suggest that PPAR γ agonists, and specifically pioglitazone, could be potential therapeutics for the treatment of binge alcohol drinking.
Source: Psychopharmacology - Category: Psychiatry Source Type: research
Regular use of proton-pump inhibitors increases patients ’ risk of developing type 2 diabetes mellitus by 24%, an observational study published in Gut has suggested.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
More News: Biology | Diabetes | Diabetes Type 2 | Endocrinology | Epidemiology | Research